NDATRANSDERMALFILM, EXTENDED RELEASE
Approved
May 2007
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
20
Mechanism of Action
Dopamine Agonists
Pharmacologic Class:
Nonergot Dopamine Agonist
Clinical Trials (5)
A Follow-up Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome
Started Dec 2019
10 enrolled
Restless Legs Syndrome
An Open, Randomised, Single Dose, 2-period, 2-sequence Crossover Adhesion Study of Two Different Transdermal Patches Containing Rotigotine.
Started Dec 2019
31 enrolled
Parkinson Disease
A Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome of Unknown Cause
Started Dec 2018
23 enrolled
Restless Legs Syndrome
Rotigotine Effect on Nocturnal Hypokinesia Compares to Placebo Control: A Quantitative Assessment by Wearable Sensors
Started Sep 2016
40 enrolled
Nocturnal Hypokinesia
Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's Disease
Started Sep 2014
195 enrolled
Idiopathic Parkinson's Disease
Loss of Exclusivity
LOE Date
Mar 1, 2032
72 months away
Patent Expiry
Mar 1, 2032